| OMNICELL INC. DL-,001 |
| USA |
| Gesundheit |
| US68213N1090 / 632313 |
| OC9 (Frankfurt) / OMCL (NASDAQ) |
| FRA:OC9, ETR:OC9, OC9:GR, NASDAQ:OMCL |
| - |
| https://www.omnicell.com/ |
|
Omnicell Inc. operates as a provider of medication management solutions and adherence tools within the healthcare industry. Its primary function is to optimize medication management and supply chain processes in healthcare facilities, aiming to enhan..
>Volltext.. |
| 1344.2 Mio. EUR |
| 1303.76 Mio. EUR |
| 1026.45 Mio. EUR |
| 80.39 Mio. EUR |
| 1.78 Mio. EUR |
| 0.04 EUR |
| 177.03 Mio. EUR |
| 217.47 Mio. EUR |
| 110.28 Mio. EUR |
| 0.53 |
| 6.53% |
| -83.62% |
| - |
| - |
| - |
| OMNICELL |
| 05.04.26 |